Globalization of P4 medicine: Predictive, personalized, preemptive, and participatory - Summary of the Proceedings of the Eighth International Symposium of the International Society for Strategic Studies in Radiology, August 27-29, 2009

Radiology

Volumn 258, Issue 2, 2011, Pages 571-582

  Bradley, William G ^a   Golding, Stephen G ^b   Herold, Christian J ^c   Hricak, Hedvig ^d   Krestin, Gabriel P ^e   Lewin, Jonathan S ^f   Miller, Janet C ^g   Ringertz, Hans G ^h   Thrall, James H ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CETUXIMAB; GEFITINIB; K RAS PROTEIN;

ARTICLE; BREAST CANCER; CANCER SCREENING; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COLON CANCER; COMMERCIAL PHENOMENA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DEGENERATIVE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOCTOR PATIENT RELATION; DRUG RESPONSE; EARLY DIAGNOSIS; GLOBALIZATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; IMAGE ANALYSIS; JOB PERFORMANCE; LUNG CANCER; MAMMOGRAPHY; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICINE; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICIPATORY MEDICINE; PATIENT CARE; PERSONALIZED MEDICINE; PREEMPTIVE MEDICINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RADIATION SAFETY; RADIOLOGIST; RADIOLOGY; SENSITIVITY AND SPECIFICITY; SYSTEMS BIOLOGY;

BIOMEDICAL RESEARCH; DIAGNOSTIC IMAGING; FORECASTING; HUMANS; INDIVIDUALIZED MEDICINE; INTERNATIONALITY; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; PROFESSIONAL PRACTICE;

EID: 79952351439     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100568     Document Type: Article

References (84)

1. Zerhouni E. P4 medicine: the future. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
2. Ma QY. Time-medical presentation. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
3. Wickersham IR, Lyon DC, Barnard RJ, et al. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 2007;53(5):639-647. (Pubitemid 46283372)
4. Massoud TF, Gambhir SS. Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med 2007;13(5):183-191. (Pubitemid 46687127)
5. Manolio TA, Brooks LD, Collins FS. A Hap-Map harvest of insights into the genetics of common disease. J Clin Invest 2008;118(5):1590-1605. (Pubitemid 351632361)
6. Kuhl CK. Screening for breast cancer. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
7. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
8. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;353(17):1773-1783. (Pubitemid 41549889)
9. Berg WA, Weinberg IN, Narayanan D, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 2006;12(4):309-323.
10. Manser RL, Irving LB, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev 2004;(1):CD001991.
11. Hillman BJ;ACRIN. Economic, legal, and ethical rationales for the ACRIN national lung screening trial of CT screening for lung cancer. Acad Radiol 2003;10(3):349-350.
12. Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncol 2008;9(7):693-697.
13. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds. Br J Cancer 2005;92(2):241-245. (Pubitemid 40343136)
14. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005;23(12):2772-2780. (Pubitemid 46179467)
15. Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997;202(3):697-702. (Pubitemid 27093440)
16. Costouros NG, Coakley FV, Westphalen AC, et al. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2007;188(3):812-816.
17. Golman K, in 't Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Acad Sci U S A 2006;103(30):11270-11275.
18. 13C MR spectroscopy. J Nucl Med 2008;49(3):341-344.
19. 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res 2008;68(20):8607-8615.
20. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359(12):1207-1217.
21. Regge D, Laudi C, Galatola G, et al. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. JAMA 2009;301(23):2453-2461.
22. Graser A, Stieber P, Nagel D, et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 2009;58(2):241-248.
23. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134(5):1570-1595.
24. Brewer JB, Magda S, Airriess C, Smith ME. Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. AJNR Am J Neuroradiol 2009;30(3):578-580.
25. Brewer JB. Fully-automated volumetric MRI with normative ranges: translation to clinical practice. Behav Neurol 2009;21(1):21-28.
26. Kovacevic S, Rafii MS, Brewer JB;Alzheimer's Disease Neuroimaging Initiative. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 2009;23(2):139-145.
27. Brewer JB. Screening for Alzheimer's disease using MR morphometry. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
28. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12(1):56-62.
29. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92(3):657-671.
30. Davies MJ. Stability and instability: two faces of coronary atherosclerosis - The Paul Dudley White Lecture 1995. Circulation 1996;94(8):2013-2020.
31. Leber AW, Becker A, Knez A, et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 2006;47(3):672-677. (Pubitemid 43170862)
32. Boll DT, Hoffmann MH, Huber N, Bossert AS, Aschoff AJ, Fleiter TR. Spectral coronary multidetector computed tomography angiography: dual benefit by facilitating plaque characterization and enhancing lumen depiction. J Comput Assist Tomogr 2006;30(5):804-811. (Pubitemid 44368222)
33. Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005;25(1):234-239. (Pubitemid 40054282)
34. Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005;112(22):3437-3444.
35. Saam T, Cai J, Ma L, et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 2006;240(2):464-472. (Pubitemid 44098643)
36. Aziz K, Berger K, Claycombe K, Huang R, Patel R, Abela GS. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation 2008;117(16):2061-2070. (Pubitemid 351572167)
37. Rominger A, Saam T, Wolpers S, et al. 18FFDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 2009;50(10):1611-1620.
38. Gaster RS, Hall DA, Nielsen CH, et al. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat Med 2009;15(11):1327-1332.
39. D'Souza AL, Tseng JR, Pauly KB, et al. A strategy for blood biomarker amplification and localization using ultrasound. Proc Natl Acad Sci U S A 2009;106(40):17152-17157.
40. De la Zerda A, Zavaleta C, Keren S, et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008;3(9):557-562.
41. Zavaleta CL, Smith BR, Walton I, et al. Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy. Proc Natl Acad Sci U S A 2009;106(32):13511-13516.
42. McNeill BJ. Getting better evidence for payment for radiology services. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
43. Dhruva SS, Phurrough SE, Salive ME, Redberg RF. CMS's landmark decision on CT colonography - examining the relevant data. N Engl J Med 2009;360(26):2699-2701.
44. Hillner BE, Siegel BA, Shields AF, et al. Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry. J Nucl Med 2008;49(12):1928-1935.
45. Hillman BJ. Lessons learned from ACRIN. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
46. Aspelin P. How can clinical research and healthcare be improved? Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
47. Efroni S, Schaefer CF, Buetow KH. Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS One [serial online] 2007;2(5):e425. Accessed October 12, 2010.
48. Stilgenbauer S, Sander S, Bullinger L, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007;92(9):1242-1245. (Pubitemid 350144184)
49. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006;354(23):2431-2442. (Pubitemid 43855046)
50. 18F-FDG in patients with progressive, metastatic prostate cancer. J Nucl Med 2004;45(3):366-373.
51. Zhao B, Schwartz LH, Larson SM. Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers. J Nucl Med 2009;50(2):239-249.
52. Perez EA. Cardiac toxicity of ErbB2-targeted therapies: what do we know? Clin Breast Cancer 2008;8(suppl 3):S114-S120.
53. Tuma RS. Economic analysis: big savings with KRAS testing. Oncol Times 2009;31(6):41-43.
54. Eberhard DA, Johnson BE, Amler LC, et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 2005;23(25):5900-5909.
55. Geraldes CF, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2009;4(1):1-23.
56. Breier A, Su TP, Saunders R, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 1997;94(6):2569-2574.
57. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55(3):306-319. (Pubitemid 38269583)
58. Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. Eur J Nucl Med Mol Imaging 2008;35(suppl 1):S46-S50.
59. Frericks BB, Loddenkemper C, Huppertz A, et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol 2009;193(4):1053-1060.
60. Nunn AD. The cost of developing imaging agents for routine clinical use. Invest Radiol 2006;41(3):206-212. (Pubitemid 44406180)
61. Neves AA, Krishnan AS, Kettunen MI, et al. A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging. Nano Lett 2007;7(5):1419-1423. (Pubitemid 46834432)
62. Mulder WJ, Strijkers GJ, Habets JW, et al. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005;19(14):2008-2010. (Pubitemid 41759747)
63. Hamm BK. Personalized treatment: need for non-personalized probes for molecular imaging. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
64. Iglehart JK. Health insurers and medical-imaging policy: a work in progress. N Engl J Med 2009;360(10):1030-1037.
65. Bautista AB, Burgos A, Nickel BJ, et al. Do clinicians use the American College of Radiology appropriateness criteria in the management of their patients? AJR Am J Roentgenol 2009;192(6):1581-1585.
66. Seltzer SM. Managing radiology utilization. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
67. Sistrom CL, Dang PA, Weilburg JB, Dreyer KJ, Rosenthal DI, Thrall JH. Effect of computerized order entry with integrated decision support on the growth of outpatient procedure volumes: seven-year time series analysis. Radiology 2009;251(1):147-155.
68. Lauer MS. Elements of danger: the case of medical imaging. N Engl J Med 2009;361(9):841-843.
69. Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007;357(22):2277-2284. (Pubitemid 350190758)
70. Cardis E, Vrijheid M, Blettner M, et al. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res 2007;167(4):396-416. (Pubitemid 351292972)
71. Kendall GM, Muirhead CR, MacGibbon BH, et al. Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers. BMJ 1992;304(6821):220-225.
72. Williams D. Twenty years' experience with post-Chernobyl thyroid cancer. Best Pract Res Clin Endocrinol Metab 2008;22(6):1061-1073.
73. Pfeiffer F, Bunk O, David C, et al. Highresolution brain tumor visualization using three-dimensional x-ray phase contrast tomography. Phys Med Biol 2007;52(23):6923-6930. (Pubitemid 350150622)
74. Thrall JH. Non-invisible radiologist/face of radiology. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
75. Glazer GM. Creation of a patient-centered radiology facility: what patients want. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
76. Patti JA, Berlin JW, Blumberg AL, et al. ACR white paper: the value added that radiologists provide to the health care enterprise. J Am Coll Radiol 2008;5(10):1041-1053.
77. Lewis RS, Sunshine JH, Bhargavan M. Radiology practices' use of external off-hours teleradiology services in 2007 and changes since 2003. AJR Am J Roentgenol 2009;193(5):1333-1339.
78. Cut costs one at a time. Telerays Web site. http://www.telerays.com/ index.html. Published 2008. Accessed October 29, 2009.
79. Lewin JS, Nour SG, Meyers ML, et al. Intraoperative MRI with a rotating, tiltable surgical table: a time use study and clinical results in 122 patients. AJR Am J Roentgenol 2007;189(5):1096-1103. (Pubitemid 350032998)
80. Hall WA, Kowalik K, Liu H, Truwit CL, Kucharezyk J. Costs and benefits of intraoperative MR-guided brain tumor resection. Acta Neurochir Suppl (Wien) 2003;85:137-142. (Pubitemid 38446162)
81. Bradley WG Jr. MR-guided focused ultrasound: a potentially disruptive technology. J Am Coll Radiol 2009;6(7):510-513.
82. Roberts A. MR-guided focused ultrasound in the body. Presented at the 8th Biennial International Symposium of the International Society for Strategic Studies in Radiology, San Diego, Calif, August 27-29, 2009.
83. Liberman B, Gianfelice D, Inbar Y, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol 2009;16(1):140-146.
84. Martin E, Jeanmonod D, Morel A, Zadicario E, Werner B. High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol 2009;66(6):858-861.